期刊文献+

维持性血液透析退出患者铁代谢特点及危险因素分析 被引量:3

Analysis of iron metabolism characteristics and risk factors in patients with maintenance hemodialysis withdrawal
下载PDF
导出
摘要 目的 分析退出血液透析患者的铁代谢特点,并进一步探讨影响患者退出血液透析的高危因素。方法 以2011年1月至2014年1月期间本院血液透析患者为研究对象,收集其基本项目、临床资料、实验室检查包括营养状态、炎症反应、铁代谢等临床资料。采用COX回归进行多因素统计学分析。结果 两组患者在年龄、性别、基础病等一般资料方面差异无统计学意义,而退出组总铁结合力明显高于未退出组;多因素回归分析显示总铁结合力增高、血蛋白降低及酸中毒为患者退出透析的独立危险因素。结论 总铁结合力升高是退出透析患者的铁代谢特点,其与低蛋白、酸中毒一起均是血透患者退出透析的独立危险因素。 Objective To analyze the pathological characteristics of iron metabolism in patients who have dropped out hemodialysis,and risk factors.Methods A 3-year research was conducted at the kidney disease centre of our hospital to determine the risk factors which affect the life quality of maintenance hemodialysis(MHD)patients.The clinical data such as iron metabolism and biochemical indicators were examined among 169 patients with end-stage renal disease(ESRD).Results Of 169 patients with MHD,30 cases quitted dialysis due to various adverse outcomes(death,transfer to peritoneal dialysis),and the other 139 cases were still in our centre to receive hemodialysis.The serum ferritin increased in both groups,while the changes of serum total iron-binding capacity(TIBC),blood albumin level,and carbon dioxide binding force were significantly different.The COX regression analysis showed that the TIBC,albumin,and carbon dioxide binding force were the independent factors which influenced the life quality of dialysis patients.Conclusion The detection of iron parameters in MHD patients should be strengthened,the intravenous iron treatment should be carefully conducted,and doctors should correct malnutrition and maintain the electrolyte and acid-base balance clinically for MHD patients,in order to improve their life quality.
作者 杨椹 张云芳 田鲁 化宝军 赵世莉 王琦 Yang Shen;Zhang Yunfang;Tian Lu;Hua Baojun;Zhao Shili;Wang Qi(Department of Nephrology,Huadu District People's Hospital of Guangzhou,Guangzhou 510800,China)
出处 《国际医药卫生导报》 2018年第23期3539-3541,共3页 International Medicine and Health Guidance News
基金 广东省自然科学基金(2016A030313420) 广东省科技计划项目(粤科规财【2015】110号0024) 广州市医学重点学科建设项目(2017-2020) 广州市花都区科技计划项目(17-HDWS-001).
关键词 终末期肾病 铁代谢 总铁结合力 血液透析 危险因素 End-stage renal disease Iron metabolism Total iron-binding capacity Hemodialysis Risk factor
  • 相关文献

参考文献2

二级参考文献21

  • 1Portoles J, Lopez-Gomez JM, Aljama P. Anemia management and treatment response in patients on hemodialysis: the MAR study[J]. J Nephrol, 2006,19:352- 360.
  • 2KDOOI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease[J]. Am J Kidney Dis, 2006,47:S11-145.
  • 3Brookhart MA, Schneeweiss S, Avorn J, et al. The effect of altitude on dosing and response to erythropoietin in ESRD [J]. J Am Soc Nephrol, 2008,19:1389- 1395.
  • 4Riedel MK, Morgenstern T. Iron replacement in hemodialysis patients with a normal serum ferritin level[J]. Dtseh Med Wochenschr, 2004,129:1849 1853.
  • 5Jacobs C, Frei D, Perkins AC. Results of the European Survey on Anaemia Management 2003 (ESAM 2003): current status of anaemia management in dialysis patients, factors affecting epoetin dosage and changes in anaemia management over the last 5 years[J]. Nephrol Dial Transplant, 2005,20 Suppl 3:iii3 -24.
  • 6Reis KA, Guz G, Ozdemir H, et al. Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease[J]. Int Heart J, 2005,46:255-264.
  • 7Lenga I, Lok C, Marticorena R, et al. Role of oral iron in the management of long term hemodialysis patients[J], Clin J Am Soe Nephrol, 2007,2:688-693.
  • 8Rozen Zvi B, Gafter Gvili A, Paul M, et al. Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta anaIysls[J]. Am J Kidney Dis, 2008,52:897-906.
  • 9Sargent JA, Acchiardo SR. Iron requirements in hemodialysis [J]. Blood Purif. 2004,22:112-123.
  • 10Anirban G, Kohli HS, Jha V, et al. The comparative safety of various intravenous iron preparations in chronic kidney disease patients[J]. Ren Fail, 2008,30:629-638.

共引文献18

同被引文献29

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部